Akkhie Prakarn PCL (BKK:AKP)

Revance Therapeutics Revenue

Akkhie Prakarn PCL had revenue of 80.46M THB in the quarter ending March 31, 2025, a decrease of -0.39%. This brings the company's revenue in the last twelve months to 345.33M, down -5.54% year-over-year. In the year 2024, Akkhie Prakarn PCL had annual revenue of 345.64M, down -5.80%.

• Revenue (ttm): 345.33M
• Revenue Growth: -5.54%
• P/S Ratio: 0.66
• Revenue / Employee: 1.63M
• Employees: 212
• Market Cap: 226.24M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	345.64M	-21.27M	-5.80%
Dec 31, 2023	366.91M	-8.23M	-2.19%
Dec 31, 2022	375.14M	-122.25K	-0.03%
Dec 31, 2021	375.27M	27.72M	7.98%
Dec 31, 2020	347.55M	-69.66M	-16.70%